Pantothenate kinase-associated neurodegeneration

References

1. ↵
   1. Sethi KD,
   2. Adams RJ,
   3. Loring DW,
   4. el Gammal T

   (1988) Hallervorden-Spatz syndrome:clinical and magnetic resonance imaging correlations. Ann Neurol 24, 692–694.
2. ↵
   1. Zhou B,
   2. Westaway SK,
   3. Levinson B,
   4. Johnson MA,
   5. Gitschier J,
   6. Hayflick SJ

   (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28, 345–349.
3. ↵
   1. Schneider SA,
   2. Hardy J,
   3. Bhatia KP

   (2009) Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2:causative or consequential? J Neurol Neurosurg Psychiatry 80, 589–590.
4. ↵
   1. Gregory A,
   2. Hayflick SJ

   (2013) Pantothenate Kinase-Associated Neurodegeneration. GeneReviews.
5. ↵
   1. Mikati MA,
   2. Yehya A,
   3. Darwish H,
   4. Karam P,
   5. Comair Y

   (2009) Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 13, 61–64.